Cargando…
Safety Evaluation of an Expedited Omalizumab Home Self-Administration Pathway
Introduction The Northern Ireland Regional Immunology Service (NIRIS) has developed an expedited omalizumab home self-administration pathway to reduce face-to-face clinic attendance during the coronavirus disease 2019 (COVID-19) pandemic. This audit evaluates the safety of this pathway with a partic...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584126/ https://www.ncbi.nlm.nih.gov/pubmed/34790499 http://dx.doi.org/10.7759/cureus.19434 |